NEMAX
Price
$20.05
Change
+$0.23 (+1.16%)
Updated
Jan 30 closing price
Net Assets
188.71M
VEIEX
Price
$28.29
Change
+$0.31 (+1.11%)
Updated
Jan 30 closing price
Net Assets
108.96B
Ad is loading...

NEMAX vs VEIEX

Header iconNEMAX vs VEIEX Comparison
Open Charts NEMAX vs VEIEXBanner chart's image
Neuberger Berman Emerg Mkts Eq A
Price$20.05
Change+$0.23 (+1.16%)
VolumeN/A
Net Assets188.71M
Vanguard Emerging Mkts Stock Idx I
Price$28.29
Change+$0.31 (+1.11%)
VolumeN/A
Net Assets108.96B
NEMAX vs VEIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NEMAX vs. VEIEX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEMAX is a Buy and VEIEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 109B vs. NEMAX (189M). VEIEX pays higher dividends than NEMAX: VEIEX (3.27) vs NEMAX (1.15). NEMAX was incepted earlier than VEIEX: NEMAX (16 years) vs VEIEX (31 years). NEMAX is a more actively managed with annual turnover of: 58.00 vs. VEIEX (5.00). VEIEX has a lower initial minimum investment than NEMAX: VEIEX (0) vs NEMAX (1000). NEMAX annual gain was more profitable for investors over the last year : 15.91 vs. VEIEX (13.72). VEIEX return over 5 years is better than : 14.98 vs. NEMAX (2.73).
NEMAXVEIEXNEMAX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years31 years-
Gain YTD0.968-0.143-678%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRA1000N/A-
Net Assets189M109B0%
Annual Yield % from dividends1.153.2735%
Returns for 1 year15.9113.72116%
Returns for 3 years-9.11-4.29212%
Returns for 5 years2.7314.9818%
Returns for 10 years27.8627.85100%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMPX3.340.16
+5.03%
Amprius Technologies
GPI461.9412.49
+2.78%
Group 1 Automotive
ARES198.084.66
+2.41%
Ares Management Corp
ENLV1.11N/A
+0.09%
Enlivex Therapeutics Ltd
PFBC90.38-0.55
-0.60%
Preferred Bank